Fibrosarcoma versus cellular fibroma of the ovary: A comparative study of their proliferative activity and chromosome aberrations using MIB-1 immunostaining, DNA flow cytometry, and fluorescence in situ hybridization

American Journal of Surgical Pathology

Volumn 21, Issue 1, 1997, Pages 52-59

  Tsuji, Takahiro ^a   Kawauchi, Shigeto ^a   Utsunomiya, Takashi ^a   Nagata, Yukihiro ^b   Tsuneyoshi, Masazumi ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b KAGOSHIMA UNIVERSITY   (Japan)

Author keywords

Cellular fibroma; DNA flow cytometry; Fibrosarcoma; Fluorescence in situ hybridization (FISH); MIB 1; Ovary

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CELL PROLIFERATION; CHROMOSOME 12; CHROMOSOME 17; CHROMOSOME 8; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; FEMALE; FIBROMA; FIBROSARCOMA; FLOW CYTOMETRY; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; HUMAN TISSUE; TRISOMY 8; TUMOR CLASSIFICATION;

ADOLESCENT; ADULT; AGED; ANTIGENS, NUCLEAR; AUTOANTIGENS; CELL DIVISION; CHROMOSOME ABERRATIONS; DNA, NEOPLASM; FEMALE; FIBROMA; FIBROSARCOMA; FLOW CYTOMETRY; HUMANS; IMMUNOENZYME TECHNIQUES; IN SITU HYBRIDIZATION, FLUORESCENCE; KI-67 ANTIGEN; MIDDLE AGED; NUCLEAR PROTEINS; OVARIAN NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 0031030451     PISSN: 01475185     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000478-199701000-00006     Document Type: Article

References (32)

1. Cattoretti G, Becker MHG, Key G, et al. Monoclonal antibodies against recombinant parts of the Ki-67 antigen (MIB1 and MIB3) detect proliferating cells in microwave-processed formalin-fixed paraffin sections. J Pathol 1992;168:357-63.
2. Donhuijsen K, Schmidt U, Hirche H, van Beuningen D, Budach V. Changes in mitotic rate and cell cycle tractions caused by delayed fixation. Hum Pathol 1990;21:709-14.
3. Fletcher JA, Gibas Z, Donovan K, et al. Ovarian granulosa-stromal cell tumors are characterized by trisomy 12. Am J Pathol 1991; 138:515-20.
4. Fletcher JA, Naeem R, Xiao S, Corson JM. Chromosome aberrations in desmoid tumors: trisomy 8 may be a predictor of recurrence. Cancer Genet Cytogenet 1995;79:139-13.
5. Hirakawa N, Naka T, Yamamoto I, Fukuda T, Tsuneyoshi M. The overexpression of bcl-2 protein in synovial sarcoma - with a comparative study of other soft tissue spindle cell sarcomas and an additional analysis by fluorescence in situ hybridization. Hum Pathol 1996;27:1060-5.
6. Hopman AHN, Ramaekers FCS, Raap AK, et al. In situ hybridization as a tool to study numerical chromosome aberrations in solid bladder tumors. Histochemistry 1988;89:307-16.
7. Kreicbergs A, Tribukait B, Willems J, Bauer HCF. DNA flow analysis of soft tissue tumors. Cancer 1987;59:128-33.
8. Leung WY, Schwartz PE, Ng HT, Yang-Feng TL. Trisomy 12 in benign fibroma and granulosa cell tumor of the ovary. Gynecol Oncol 1990;38:28-31.
9. Mandahl N, Heim S, Rydholm A, Willen H, Mitelman F. Nonrandom numerical chromosome aberrations (+8, +11, +17, +20) in infantile fibrosarcoma. Cancer Genet Cytogenel 1989;40:137-9.
10. Mrozek K, Nedoszytko B, Babinska M, et al. Trisomy of chromosome 12 in a case of thecoma of the ovary. Gynecol Oncol 1990; 36:413-6.
11. Mugneret F, Lizard S, Aurias A, Turc-Carel C. Chromosomes in Ewing's sarcoma. II. Nonrandom additional changes, trisomy 8 and der (16)t(1;16). Cancer Genet Cytogenet 1988;32:239-45.
12. Naeem R, Lux ML, Huang SF, Naber SP, Corson JM, Fletcher JA. Ring chromosomes in dermatofibrosarcoma protuberans are composed of interspersed sequences from chromosomes 17 and 22. Am J Pathol 1995;147:1553-8.
13. Oshiro Y, Fukuda T, Tsuneyoshi M. Fibrosarcoma versus fibromatoses and cellular nodular fasciitis: a comparative study of their proliferative activity using proliferating cell nuclear antigen. DNA now cytometry, and p53. Am J Surg Pathol 1994;18:712-9.
14. Pejovic T, Heim S, Mandahl N, et al. Trisomy 12 is a consistent chromosomal aberration in benign ovarian tumors. Genes Chrom Cancer 1990;2:48-52.
15. Persons DL, Hartmann LC, Herath JF, et al. Interphase molecular cytogenetic analysis of epithelial ovarian carcinomas. Am J Pathol 1993;142:733-41.
16. Persons DL, Hartmann LC, Herath JF, Keeney GL, Jenkins RB. Fluorescence in situ hybridization analysis of trisomy 12 in ovarian tumors. Am J Clin Pathol 1994;102:775-9.
17. Poddighe PJ, Ramaekers FCS, Hopman AHN. Interphase cytogenetics of tumors. J Pathol 1992;166:215-24.
18. Poddighe PJ, Ramaekers FCS, Smeets AWGB, Vooijs GP, Hopman AHN. Structural chromosome 1 aberrations in transitional cell carcinoma of the bladder: interphase cytogenetics combining a centromeric, telomeric, and library DNA probe. Cancer Res 1992; 52:4929-34.
19. Prat J, Scully RE. Cellular fibromas and fibrosarcomas of the ovary: a comparative clinicopathologic analysis of seventeen cases. Cancer 1981;47:2663-70.
20. Samuelson J, Katz S, Schwartz PE, Yang-Feng TL. Chromosomal evolution through tumor progression in ovarian cancer. Am J Hum Genel 1988;43(suppl):A33.
21. Schofield DE, Fletcher JA. Trisomy 12 in pediatric granulosastromal cell tumors: demonstration by a modified method of fluorescence in situ hybridization on paraffin-embedded material. Am J Pathol 1992;141:1265-9.
22. Schofield DE, Fletcher JA, Grier HE, Yunis EJ. Fibrosarcoma in infants and children: application of new techniques. Am J Surg Pathol 1994;18:14-24.
23. Schutte B, Reynder MMJ, Bosman FT, Blijham GH. Flow cytometric determination of DNA ploidy level in nuclei isolated from paraffin-embedded tissue. Cytometry 1985;6:26-30.
24. Shashi V, Golden WL, von Kap-Herr C, Andersen WA, Gaffey MJ. Interphase fluorescence in situ hybridization for trisomy 12 on archival ovarian sex cord-stromal tumors. Gynecol Oncol 1994;55: 349-54.
25. Speleman F, Dal Cin P, De Potter K, et al. Cytogenetic investigation of a case of congenital fibrosarcoma. Cancer Genet Cytogenet 1989;39:21-4.
26. Sreekantaiah C, Karakousis CP, Leong SP, Sandberg AA. Trisomy 8 as a nonrandom secondary change in myxoid liposarcoma. Cancer Genet Cytogenet 1991;51:195-205.
27. Stenfert Kroese MC, Rutgers DH, Wils IS, Van Unnik JAM, Roholl PJM. The relevance of the DNA index and proliferation rate in the grading of benign and malignant soft tissue tumors. Cancer 1990;65:1782-8.
28. Takahashi S, Qian J, Brown JA, et al. Potential markers of prostate cancer aggressiveness detected by fluorescence in situ hybridization in needle biopsies. Cancer Res 1994;54:3574-9.
29. Taruscio D, Carcangin ML, Ward DC. Detection of trisomy 12 on ovarian sex cord stromal tumors by fluorescence in situ hybridization. Diagnos Molec Pathol 1993;2(2):94-8.
30. Ueda T, Aozasa K, Tsujimoto M, et al. Prognostic significance of Ki-67 reactivity in soft tissue sarcomas. Cancer 1989;63:1607-11.
31. Vindeløv LL, Christensen IJ, Nissen NI. A detergent trypsin method for the preparation of nuclei for flow cytometric DNA analysis. Cytometry 1983;3:323-7.
32. Xiang J, Spanier SS, Benson NA, Braylan RC. Flow cytometric analysis of bone and soft-tissue tumor using nuclear suspensions. Cancer 1987;59:1951-8.